BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26452665)

  • 1. RAD51 and BRCA2 Enhance Oncolytic Adenovirus Type 5 Activity in Ovarian Cancer.
    Tookman LA; Browne AK; Connell CM; Bridge G; Ingemarsdotter CK; Dowson S; Shibata A; Lockley M; Martin SA; McNeish IA
    Mol Cancer Res; 2016 Jan; 14(1):44-55. PubMed ID: 26452665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
    Trenner A; Godau J; Sartori AA
    Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
    Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
    Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA2: one small step for DNA repair, one giant protein purified.
    Jensen RB
    Yale J Biol Med; 2013 Dec; 86(4):479-89. PubMed ID: 24348212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
    Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
    Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between BRCA2 and RAD51 for promoting homologous recombination in Leishmania infantum.
    Genois MM; Mukherjee A; Ubeda JM; Buisson R; Paquet E; Roy G; Plourde M; Coulombe Y; Ouellette M; Masson JY
    Nucleic Acids Res; 2012 Aug; 40(14):6570-84. PubMed ID: 22505581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication fork reversal triggers fork degradation in BRCA2-defective cells.
    Mijic S; Zellweger R; Chappidi N; Berti M; Jacobs K; Mutreja K; Ursich S; Ray Chaudhuri A; Nussenzweig A; Janscak P; Lopes M
    Nat Commun; 2017 Oct; 8(1):859. PubMed ID: 29038466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation.
    Kwon Y; Rösner H; Zhao W; Selemenakis P; He Z; Kawale AS; Katz JN; Rogers CM; Neal FE; Badamchi Shabestari A; Petrosius V; Singh AK; Joel MZ; Lu L; Holloway SP; Burma S; Mukherjee B; Hromas R; Mazin A; Wiese C; Sørensen CS; Sung P
    Nat Commun; 2023 Jan; 14(1):432. PubMed ID: 36702902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.
    Lodhia KA; Gao S; Aleksic T; Esashi F; Macaulay VM
    Int J Cancer; 2015 Jun; 136(12):2961-6. PubMed ID: 25388513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
    Roberti M; Schipani F; Bagnolini G; Milano D; Giacomini E; Falchi F; Balboni A; Manerba M; Farabegoli F; De Franco F; Robertson J; Minucci S; Pallavicini I; Di Stefano G; Girotto S; Pellicciari R; Cavalli A
    Eur J Med Chem; 2019 Mar; 165():80-92. PubMed ID: 30660828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication-competent adenovirus formation in 293 cells: the recombination-based rate is influenced by structure and location of the transgene cassette and not increased by overproduction of HsRad51, Rad51-interacting, or E2F family proteins.
    Duigou GJ; Young CS
    J Virol; 2005 May; 79(9):5437-44. PubMed ID: 15827158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moonlighting at replication forks - a new life for homologous recombination proteins BRCA1, BRCA2 and RAD51.
    Kolinjivadi AM; Sannino V; de Antoni A; Técher H; Baldi G; Costanzo V
    FEBS Lett; 2017 Apr; 591(8):1083-1100. PubMed ID: 28079255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer.
    Lee JM; Gordon N; Trepel JB; Lee MJ; Yu M; Kohn EC
    J Transl Med; 2015 Jul; 13():239. PubMed ID: 26198537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
    Cousineau I; Belmaaza A
    Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous recombination deficiency real-time clinical assays, ready or not?
    Fuh K; Mullen M; Blachut B; Stover E; Konstantinopoulos P; Liu J; Matulonis U; Khabele D; Mosammaparast N; Vindigni A
    Gynecol Oncol; 2020 Dec; 159(3):877-886. PubMed ID: 32967790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
    Park JY; Singh TR; Nassar N; Zhang F; Freund M; Hanenberg H; Meetei AR; Andreassen PR
    Oncogene; 2014 Oct; 33(40):4803-12. PubMed ID: 24141787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brca2, Rad51 and Mre11: performing balancing acts on replication forks.
    Costanzo V
    DNA Repair (Amst); 2011 Oct; 10(10):1060-5. PubMed ID: 21900052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
    Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
    J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer.
    Raki M; Särkioja M; Desmond RA; Chen DT; Bützow R; Hemminki A; Kanerva A
    Gynecol Oncol; 2008 Jan; 108(1):166-72. PubMed ID: 17950450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.
    Guffanti F; Alvisi MF; Anastasia A; Ricci F; Chiappa M; Llop-Guevara A; Serra V; Fruscio R; Degasperi A; Nik-Zainal S; Bani MR; Lupia M; Giavazzi R; Rulli E; Damia G
    Br J Cancer; 2022 Jan; 126(1):120-128. PubMed ID: 34732853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.